Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Hosted on MSN
Compass Therapeutics drops sharply as trial crossover complicates survival data in bile duct cancer patients
Compass Therapeutics Inc. CMPX shares are tumbling on Monday as the company announced results from its COMPANION-002 study, which evaluated its drug tovecimig in patients with advanced biliary tract ...
Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results